Clinical practice. Bacterial diarrhea.
暂无分享,去创建一个
[1] P. Tarr. Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis. , 2009, Kidney international. Supplement.
[2] P. Cieslak,et al. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] P. Cieslak,et al. Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study , 2008, Annals of the rheumatic diseases.
[4] M. Waldor,et al. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. , 2000, The Journal of infectious diseases.
[5] L B Reller,et al. Practice guidelines for the management of infectious diarrhea. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] M. Tobin-D'Angelo,et al. Continued decline in the incidence of Campylobacter infections, FoodNet 1996-2006. , 2008, Foodborne pathogens and disease.
[7] C. Walker,et al. Rifaximin Does Not Induce Toxin Production or Phage-Mediated Lysis of Shiga Toxin-Producing Escherichia coli , 2007, Antimicrobial Agents and Chemotherapy.
[8] H. Dupont,et al. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] H. Dupont,et al. A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North American travelers to Mexico. , 2009, The Journal of infectious diseases.
[10] H. Dupont,et al. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. , 2009, The American journal of tropical medicine and hygiene.
[11] Matthew R Moore,et al. Surveillance for sporadic foodborne disease in the 21st century: the FoodNet perspective. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] J. Wells,et al. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. , 2005, The Journal of infectious diseases.
[13] M. Kollef,et al. Increase in Adult Clostridium difficile–related Hospitalizations and Case-Fatality Rate, United States, 2000–2005 , 2008, Emerging infectious diseases.
[14] L. Slutsker,et al. Etiology of bloody diarrhea among patients presenting to United States emergency departments: prevalence of Escherichia coli O157:H7 and other enteropathogens. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] H. Dupont,et al. Influence of Host Interleukin-10 Polymorphisms on Development of Traveler's Diarrhea Due to Heat-Labile Enterotoxin-Producing Escherichia coli in Travelers from the United States Who Are Visiting Mexico , 2008, Clinical and Vaccine Immunology.
[16] Z. Samra,et al. Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile. , 2008, The Journal of hospital infection.
[17] A. Lavy,et al. Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] P. Gerner-Smidt,et al. The significance of the number of submitted samples and patient-related factors for faecal bacterial diagnostics. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[19] H. Dupont,et al. Expert review of the evidence base for prevention of travelers' diarrhea. , 2009, Journal of travel medicine.
[20] U. Fagundes-neto,et al. Age-specific prevalence of diffusely adherent Escherichia coli in Brazilian children with acute diarrhoea. , 2008, Journal of medical microbiology.
[21] Hyojin Park,et al. The Clinical Course of Postinfectious Irritable Bowel Syndrome: A Five-year Follow-up Study , 2009, Journal of clinical gastroenterology.
[22] David W Ussery,et al. Characterization of probiotic Escherichia coli isolates with a novel pan-genome microarray , 2007, Genome Biology.
[23] H. Törnblom,et al. Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[24] M. Tobin-D'Angelo,et al. Preliminary FoodNet Data on the incidence of infection with pathogens transmitted commonly through food--10 States, 2008. , 2009, MMWR. Morbidity and mortality weekly report.
[25] H. Dupont,et al. Post-Diarrhea Chronic Intestinal Symptoms and Irritable Bowel Syndrome in North American Travelers to Mexico , 2004, The American Journal of Gastroenterology.
[26] Choong H. Park,et al. Clinical Spectrum of Shiga Toxin–Producing Escherichia coli (STEC) in Adults and Children , 2009, Clinical pediatrics.
[27] R. Guerrant,et al. Acute Infectious Diarrhea , 2004 .
[28] H. Dupont,et al. Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate. , 1987, JAMA.
[29] D. Milewicz,et al. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. , 2003, The Journal of infectious diseases.
[30] M. Larocco,et al. A Common Polymorphism in the Interleukin 8 Gene Promoter Is Associated with Clostridium difficile Diarrhea , 2006, The American Journal of Gastroenterology.
[31] D. Antonopoulos,et al. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. , 2008, The Journal of infectious diseases.
[32] Melinda B Davis,et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] H. Dupont,et al. A Randomized, Double-Blind, Placebo-Controlled Trial of Rifaximin To Prevent Travelers' Diarrhea , 2005, Annals of Internal Medicine.
[34] F. Gejyo,et al. Effects of Azithromycin on Shiga Toxin Production by Escherichia coli and Subsequent Host Inflammatory Response , 2002, Antimicrobial Agents and Chemotherapy.
[35] R. Spiller. Role of infection in irritable bowel syndrome , 2007, Journal of Gastroenterology.
[36] L. McCaig,et al. Food-related illness and death in the United States. , 1999, Emerging infectious diseases.
[37] R. Yolken,et al. Effect of continued oral feeding on clinical and nutritional outcomes of acute diarrhea in children. , 1988, The Journal of pediatrics.
[38] Jane W. Marsh,et al. High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[39] R. Tauxe,et al. The use of clinical profiles in the investigation of foodborne outbreaks in restaurants: United States, 1982–1997 , 2007, Epidemiology and Infection.
[40] Herbert L DuPont,et al. The growing threat of foodborne bacterial enteropathogens of animal origin. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] C. Kelly,et al. Clostridium difficile--more difficult than ever. , 2008, The New England journal of medicine.
[42] H. Dupont,et al. Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study. , 2008, Journal of travel medicine.
[43] S. Groshong,et al. A rare presentation of ischemic pseudomembranous colitis due to Escherichia coli O157:H7. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[44] A. Blanch,et al. Genotypic and Phenotypic Diversity among Induced, stx2-Carrying Bacteriophages from Environmental Escherichia coli Strains , 2008, Applied and Environmental Microbiology.
[45] C. Hedberg,et al. Food-related illness and death in the United States. , 1999, Emerging infectious diseases.
[46] Sandra Romero-Steiner,et al. The Second International Conference on Women and Infectious Diseases , 2006 .
[47] R. Spiller,et al. Prognosis in post-infective irritable bowel syndrome: a six year follow up study , 2002, Gut.
[48] H. Dupont,et al. Expert review of the evidence base for self-therapy of travelers' diarrhea. , 2009, Journal of travel medicine.
[49] I. Petersen,et al. Incidence of Guillain-Barré syndrome among patients with Campylobacter infection: a general practice research database study. , 2006, The Journal of infectious diseases.